Cingal
Cingal
Cingal
Cingal is the first and only approved combination of viscosupplement formulated to provide the benefit of a cross-linked hyaluronic acid (HA) and a fast acting steroid to effectively treat the symptoms associated with osteoarthritis.
The fast acting, long lasting pain relief from osteoarthritis with anti-Inflammatory property.
Cingal is a powerful, first in-class treatment that combines the benefits of Anika’s proprietary cross-linked HA formulation of Monovisc, with a well-established FDA-approved steroid to treat inflammation and provide additional short-term pain relief. It has a strong safety profile in both an initial injection as well as a repeat injection.
Cingal: A One-Injection Combination of Hyaluronic Acid and Fast-Acting Steroid
Cingal® is the first and only approved combination viscosupplement formulated to provide the benefit of a cross-linked hyaluronic acid (HA) and a fast-acting steroid to effectively treat the symptoms associated with osteoarthritis (OA). It is a powerful, first-in-class treatment that combines the benefits of Anika’s proprietary HA formulation of Monovisc®, proven to deliver up to 6 months of relief of the symptoms of OA, with a well-established FDA-approved steroid, triamcinolone hexacetonide (TH), to treat inflammation and provide additional short-term pain relief.
Cingal extends the benefits of Anika’s proprietary HA formulation to a broader range of patients across the spectrum of osteoarthritis pain.
Key Features & Benefits